Cimpress reports fiscal Q4 results tomorrow against a backdrop where short sellers have been quietly rebuilding positions over the past month and options traders have turned measurably more defensive than usual.
The most pressing data point is the earnings event itself, scheduled for July 30. The last two quarterly prints were sharply positive — the April 30 result drove a 15% single-day gain and a 13% five-day gain, while the prior quarter added roughly 7% on the day and 8% over the following week. That reaction history sets a high bar. The stock has already climbed 9% over the past month to $100.12, suggesting some of that optimism is already priced in.
Short positioning tells a more complicated story heading into the print. At 8.8% of the free float — up 11% over the past month — short interest is elevated and has been climbing steadily since late June, when it ran near 7.9% of float. The week-on-week reading dipped 5%, but the broader monthly trend is clearly higher, with shorts adding exposure through most of July. Cost to borrow remains negligible at 0.52%, so this isn't a crowded squeeze setup. Availability is comfortable at 222%, well above the 52-week tightest reading of 211% — there is no shortage of shares for new shorts to locate. The ORTEX short score of 73.3 places the stock in the upper quartile of bearish positioning signals across the universe. Options are drifting more cautious: the put/call ratio has risen to 0.53, about 1.5 standard deviations above its 20-day average of 0.46, a move that stands out in a name where PCR rarely strays far from 0.44-0.50. Collectively, the positioning picture is one of measured caution rather than outright bear conviction — shorts are building, options lean defensive, but borrow conditions are loose enough that there's no mechanical pressure forcing covers.
The Street remains constructive, though coverage is thin and the most recent analyst action is now nearly three months stale. Barrington Research lifted its target to $113 after the April print, maintaining Outperform — that target sits roughly 11% above the current price, which at least passes the sanity check. No major-firm action has landed since May. The bull case rests on variable gross profit per customer growing 9% year-on-year to $75.90 and Vista segment revenue up 5%, with overall revenue reaching $1.042 billion last quarter. Bears focus on margin compression — gross margins fell to 46.7% — and stagnation in legacy categories like business cards. The analyst recommendation factor ranks in just the 49th percentile, reflecting how lightly covered this name is rather than any particular disagreement.
Institutional ownership is concentrated and mostly stable. Prescott General Partners and Janus Henderson each hold roughly 15% of shares. Founder Robert Keane retains 8.3% and added a modest 8,590 shares in May. The recent insider picture is net positive on a 90-day basis, with net purchases totalling around 62,000 shares worth $6.1 million — though the headline figure includes share awards alongside open-market activity. The CFO sold approximately $2.9 million of stock across late May, a cluster of transactions worth monitoring in the context of a stock trading near multi-year highs. Peer DLX and ACCO both moved higher on the week — up 5.4% and 8.2% respectively — while CMPR gave back a marginal 0.3%, suggesting sector-level tailwinds did not carry through to Cimpress this particular week.
The next session is therefore almost entirely about what the July 30 print delivers on margins and Vista segment momentum — and whether the reaction validates the shorts' patience or triggers another cover-driven leg higher.
See the live data behind this article on ORTEX.
Open CMPR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
